AVTX - Avalo Therapeutics, Inc.

QQQ $ 623.13 $ 0.00 (0 %)

DIA $ 469.46 $ 0.00 (0 %)

SPY $ 675.89 $ 0.00 (0 %)

TLT $ 89.94 $ 0.00 (0 %)

GLD $ 367.67 $ 0.00 (0 %)

Previous Close

$ 16.67

Open

$ 18.00

Bid

$ 11.74 x 400

Ask

$ 18.70 x 46

Day's Range

-- - --

52 Week Range

$ 3.39 - $ 19.41

Volume

319,090

Average Volume

Market Cap

219.25M

Beta (5Y Monthly)

$ 0.85

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-20-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	03-29-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	03-29-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	03-02-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-02-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-08-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-11-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-18-2019	12-31-2018	10-K
28	11-13-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-11-2018	03-31-2018	10-Q
31	04-02-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-14-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-14-2017	12-31-2016	10-K
36	11-08-2016	09-30-2016	10-Q
37	08-15-2016	06-30-2016	10-Q
38	05-16-2016	03-31-2016	10-Q
39	03-23-2016	12-31-2015	10-K
40	11-13-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Avalo Therapeutics Has Completed Enrollmen...
10/29/2025 11:13:15

12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket

Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

HC Wainwright & Co. Maintains Buy on Avalo...
09/17/2025 15:51:42

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and raises the pric...

Cantor Fitzgerald Initiates Coverage On Av...
08/15/2025 12:55:16

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Overweight rating.

Avalo Therapeutics Q2 EPS $(1.92) Misses $...
08/07/2025 11:17:40

Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(1.92) per share which missed the analyst consensus estimate of ...

12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

HC Wainwright & Co. Assumes Avalo Therapeu...
06/02/2025 10:43:19

HC Wainwright & Co. analyst Mitchell Kapoor assumes Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Pri...

12 Health Care Stocks Moving In Wednesday'...
05/14/2025 21:05:46

12 Health Care Stocks Moving In Monday's P...
05/12/2025 12:08:42

Avalo Therapeutics Q1 2025 EPS $(1.25) Bea...
05/12/2025 11:11:01

avalo-therapeutics-represents-an-attractive-pure-play-analyst-initiates-coverage-with-over-300-stock-upside

Avalo Therapeutics 'Represents An Attracti...
03/25/2025 19:20:44

Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates...

Jefferies Initiates Coverage On Avalo Ther...
03/25/2025 12:14:15

Jefferies analyst Kambiz Yazdi initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Price ...

Stifel Initiates Coverage On Avalo Therape...
03/25/2025 11:00:05

Stifel analyst Alex Thompson initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Price Ta...

HC Wainwright & Co. Reiterates Neutral on ...
03/20/2025 15:55:21

HC Wainwright & Co. analyst Edward White reiterates Avalo Therapeutics (NASDAQ:AVTX) from Neutral to Neutral.

this-costar-group-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

This CoStar Group Analyst Begins Coverage ...
02/28/2025 19:33:24

Piper Sandler Initiates Coverage On Avalo ...
02/28/2025 13:23:41

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Overweight rating and ann...

BTIG Initiates Coverage On Avalo Therapeut...
12/19/2024 17:47:31

BTIG analyst Julian Harrison initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Price Ta...

LUCID CAPITAL MARKETS Initiates Coverage O...
12/17/2024 15:45:29

LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and annou...

Avalo Therapeutics Has Received $69.4M In ...
11/12/2024 12:49:45

Proceeds from the full exercise of warrants issued in the first quarter of 2024 private placement bring the total gross proceed...